The Gene Panel Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The gene panel market has witnessed fast-paced expansion in recent years. The market valued at $2.14 billion in 2024 is projected to rise to $2.48 billion in 2025, indicating a compound annual growth rate (CAGR) of 15.5%.
The Gene Panel Global Market Report 2025 predicts that by 2029, the market size for gene panels will reach $4.37 billion, with a compound annual growth rate (CAGR) of 15.3%.
Download Your Free Sample of the 2025 Gene Panel Market Report and Uncover Key Trends Now!The key drivers in the gene panel market are:
• Increasing prevalence of chronic diseases and cancer
• Rising awareness and adoption of genetic testing
• Growth in government initiatives and healthcare expenditure
• Advancements in gene panel technology and integration of artificial intelligence.
The gene panel market covered in this report is segmented –
1) By Product And Services: Test Kits, Testing Services
2) By Technology: Amplicon-Based, Hybridization-Based, Other Technologies
3) By Design: Predesigned Gene Panel, Customized Gene Panel
4) By Application: Cancer Risk Assessment, Diagnosis Of Congenital Diseases, Pharmacogenetics, Other Applications
5) By End-User: Research Institutes, Hospital, Diagnosis Centers, Pharmaceutical Companies, Other End-Users
Subsegments:
1) By Test Kits: Predesigned Gene Panels, Customized Gene Panels
2) By Testing Services: Cancer Risk Assessment Panels, Pharmacogenetic Testing Panels, Neurological Disorder Panels, Cardiovascular Disease Panels, Rare Disease Panels
The key trends in the gene panel market are:
• Advanced gene panel technology is a key emerging trend in the market.
• Strategic collaborations are increasingly impacting the industry's dynamics.
• Personalized treatment is emerging as a significant trend in the gene panel market.
• The integration of artificial intelligence and advanced bioinformatics tools is shaping the market's future.
Major players in the gene panel market are:
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Quest Diagnostics Inc.
• Intermountain Healthcare
• Eurofins Scientific SE
• Agilent Technologies Inc.
• Illumina Inc.
• Qiagen Inc.
• OPKO Health Inc.
• Myriad Genetics Inc.
• Guardant Health Inc.
• Invitae Corp.
• Integrated DNA Technologies Inc.
• Bio-Rad Laboratories Inc.
• Novogene Corporation
• Fulgent Genetics Inc.
• MedGenome Inc.
• OriGene Technologies Inc.
• Centogene AG
• Blueprint Genetics Inc.
• BIONEER Corporation
• BGI Group Ltd.
• Vizgen Inc.
• Primbio Research Institute LLC
North America was the largest region in the gene panel market in 2024